Next Century Growth Investors LLC Makes New Investment in Billiontoone, Inc. $BLLN

Next Century Growth Investors LLC acquired a new position in Billiontoone, Inc. (NASDAQ:BLLN) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 36,659 shares of the company’s stock, valued at approximately $3,000,000. Next Century Growth Investors LLC owned about 0.08% of Billiontoone at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in BLLN. Green Alpha Advisors LLC bought a new stake in Billiontoone in the fourth quarter worth about $436,000. FNY Investment Advisers LLC bought a new stake in Billiontoone in the fourth quarter worth about $497,000. Massachusetts Financial Services Co. MA bought a new stake in Billiontoone in the fourth quarter worth about $13,373,000. Baillie Gifford & Co. bought a new stake in Billiontoone in the fourth quarter worth about $103,786,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Billiontoone in the fourth quarter worth about $1,348,000.

Billiontoone Stock Performance

Shares of BLLN stock opened at $101.12 on Monday. The firm has a market cap of $4.65 billion and a price-to-earnings ratio of 183.85. The company’s 50 day moving average is $88.03 and its 200 day moving average is $87.97. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18. Billiontoone, Inc. has a 52-week low of $61.96 and a 52-week high of $138.70.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.33. The business had revenue of $108.39 million for the quarter, compared to analysts’ expectations of $95.81 million. The business’s quarterly revenue was up 83.8% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.39) earnings per share. On average, sell-side analysts anticipate that Billiontoone, Inc. will post 0.93 EPS for the current fiscal year.

Insiders Place Their Bets

In other Billiontoone news, insider Shan Riku Sakakibara sold 8,000 shares of Billiontoone stock in a transaction on Monday, June 8th. The shares were sold at an average price of $98.22, for a total value of $785,760.00. Following the transaction, the insider directly owned 212,000 shares of the company’s stock, valued at approximately $20,822,640. The trade was a 3.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nancy Joann Johnson sold 10,582 shares of Billiontoone stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $100.47, for a total transaction of $1,063,173.54. Following the completion of the transaction, the insider directly owned 21,900 shares in the company, valued at $2,200,293. This represents a 32.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 60,750 shares of company stock valued at $5,979,598.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Guggenheim raised their price objective on shares of Billiontoone from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. Wall Street Zen raised shares of Billiontoone from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. JPMorgan Chase & Co. raised their target price on shares of Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. BTIG Research reduced their target price on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Finally, Weiss Ratings lowered shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday, June 5th. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $125.29.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.